Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report)’s share price dropped 1.4% during trading on Wednesday . The stock traded as low as $0.49 and last traded at $0.57. Approximately 3,600 shares traded hands during trading, an increase of 120% from the average daily volume of 1,637 shares. The stock had previously closed at $0.58.
Starpharma Price Performance
The firm’s 50-day moving average price is $0.61 and its 200 day moving average price is $0.67. The company has a current ratio of 4.94, a quick ratio of 4.58 and a debt-to-equity ratio of 0.07.
About Starpharma
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Featured Articles
- Five stocks we like better than Starpharma
- Stock Dividend Cuts Happen Are You Ready?
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
